Being an excellent research cluster in Indonesia that leading-edge research in field of drug development.

  • Improving the quality and quantity of translational research which is focused on the research activities in drug discovery and drug delivery system.
  • Developing research products (drugs and herbal medicine) which could be applied for patent and meet the drug’s market, as well as improving the amount of research publication.
  • Improving networking, national and international research collaborations that lead to the high quality research findings.

Ongoing Research

  • Dr. Kusmardi : Uji in vitro Tabat barito (Ficus deltoidea) sebagai antidiabetes pada zebrafish, kolaborasi antara departemen kimia dan patologi anatomi yang diaplikasikan dalam modul elektif fitokimia FKUI.
  • Dr. Ade Arsianti : Studi in silico asam galat dan turunannya sebagai agen antikanker, kolaborasi antara departemen kimia, farmasi dan biologi FKUI yang diaplikasikan dalam modul elektif bioinformatika.
  • Dr. Ade Arsianti : Sintesis dan uji in vivo senyawa heksil ester asam galat sebagai anti kanker payudara.
  • Fadilah, M.Si : Efektivitas krim Centella asiatica nanopartikel kitosan dibandingkan dengan krim Centella asiatica, krim silver sulfadiazine dan kontrol terhadap penyembuhan luka bakar dermis superfisial pada tikus.
  • Prof. Erni H Purwaningsih : Mekanisme kerja anti penuaan Acalypha indica L. terhadap beberapa parameter proses penuaan pada tikus Spraque.


Biotechnology Research Institute Universiti Malaysia Sabah




  • Arsianti, A., Astuty, H., Fadilah, (…), Tanimoto, H., Kakiuchi, K. Design and screening of gallic acid derivatives as inhibitors of malarial dihydrofolate reductase by in silico docking”. Asian Journal of Pharmaceutical and Clinical Research.
  • Arsianti, A., Fadilah, F., Erlina, L., Paramita, R.I. “Molecular docking of antimycin a3 analogs and its aromatic segments as inhibitors of apoptosis protein marker Bcl-xl and Mcl-1”. Source of the Document Asian Journal of Pharmaceutical and Clinical Research.
  • Fadilah, F., Andrajati, R., Yanuar, A., Arsianti, A. In-vitro anticancer activity combination of eugenol and simple aromatic benzoate compounds against human colon HCT-116 cells and WiDr cells”. Journal of Pharmaceutical Sciences and Research 9 (5), pp. 637-641.
  • Fadilah, F., Yanuar, A., Arsianti, A., Andrajati, R. Phenylpropanoids, eugenol scaffold, and its derivatives as anticancer. Asian Journal of Pharmaceutical and Clinical Research.